Zentek Stock (NASDAQ:ZTEK)


OwnershipChart

Previous Close

$0.67

52W Range

$0.37 - $1.24

50D Avg

$0.51

200D Avg

$0.64

Market Cap

$82.97M

Avg Vol (3M)

$211.36K

Beta

0.29

Div Yield

-

ZTEK Company Profile


Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coatings under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds. It also developing aptamers and rapid detection; and graphene oxide synthesis and graphene synthesis products. In addition, the company owns a 100% interest in the Albany graphite project located in Northern Ontario, Canada. The company was formerly known as ZEN Graphene Solutions Ltd. and changed its name to Zentek Ltd. in October 2021. Zentek Ltd. was incorporated in 2008 and is headquartered in Guelph, Canada.

Show More

Industry

Other Precious Metals

Sector

Basic Materials

Exchange

NASDAQ

ADR

-

Country

CA

Employees

10

IPO Date

Apr 02, 2012

Website

ZTEK Performance


Peer Comparison


TickerCompany
HYFTMindWalk Holdings Corp.
MBOTMicrobot Medical Inc.
QNCXQuince Therapeutics, Inc.
BYSIBeyondSpring Inc.
AMWLAmerican Well Corporation
CRDLCardiol Therapeutics Inc.
GUTSFractyl Health, Inc.
MGXMetagenomi, Inc. Common Stock
ALXOALX Oncology Holdings Inc.
HYPRHyperfine, Inc.